Telesis Bio partners with Danaher company Beckman Coulter

Financial terms of the deal were not disclosed.

More on Danaher, Telesis Bio, etc.

• Danaher Q3 Preview: Market Share Gains In Molecular Testing
• Danaher: Lofty Price, Bright Future
• Danaher Corporation (DHR) Q2 2024 Earnings Call Transcript
• Telesis Bio to delist its securities from Nasdaq
• Danaher gains as biotech and diagnostics drive Q2 beat